Experimental Treatments Show Promising Results Against Skin Cancer
Two new experimental treatments against advanced melanoma have shown promise in keeping the deadly skin cancer at bay. The British pharmaceutical firm GlaxoSmithKline developed and tested two agents, known as Dabrafenib and Trametinib, against standard chemotherapy treatments. 322 people were included in the Trametinib trial, of whom 214 took the experimental drug with the remainder … Read more
